Recalling firm
Merck Sharp & Dohme LLC
Product type
Drug
Status
Ongoing
Report date
2025-12-31
Distribution
Nationwide in the USA
Firm state
NC
Product quantity
3 - single dose kits
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental MonitoringReason for recall
Presence of particulate matter: potential presence of metal particulates in the product.
Product description
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Code / lot info
Lot #: Z014503, Exp 11/15/2027
Other recalls SPEQ maps to Environmental Monitoring
See all Environmental Monitoring recalls →Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.